Health Commission: my country's vaccine research and development number ranks first in the world

Xinhua News Agency, Qingdao, June 3 - (Reporter Mu Tetsujo, Wang Kai) Boao Forum for Asia Global Health Forum is being held in the Second Assembly of Qingdao, Shandong Province, the State Council joint prevention and control mechanism of scientific research group of special classes vaccine development working group, the National Zheng Zhongwei, director of the Medical and Health Technology Development Research Center of the Health Commission, said at the sub-forum "Achieving National Health—The R&D, Accessibility, and Affordability of New Coronary Vaccines", so far, China has basically achieved inactivated vaccines, recombinant protein vaccines, Full coverage of clinical trials of adenovirus vector vaccines, nucleic acid vaccines and other technical routes.

According to Zheng Zhongwei, my country's new crown vaccine has been deployed since last year.

According to data from the China Center for Disease Control and Prevention, in terms of vaccine use, as of April 30, my country’s new crown vaccine had a cumulative total of 265 million doses, and the reported incidence of adverse reactions was 11.

What is this concept? Zheng Zhongwei said that according to the adverse reaction monitoring of the use of the new crown vaccine by the China Centers for Disease Control and Prevention, compared with the use of various vaccines in my country in 2019, the adverse reaction rate of the new crown vaccine is lower than the average report of other types of vaccines in my country in 2019.

In addition, as of May 31, my country has provided more than 350 million doses of COVID-19 vaccine to foreign countries.

Zheng Zhongwei, said: "With the gradual release of production capacity in the second half, China's vaccine companies are constantly practicing vaccine as well Communism required goods constantly practicing asked to make greater contributions to human health community I believe that in the future China.